I 

117TH CONGRESS 

1ST SESSION H. R. 1384 

To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) 

to eliminate the separate registration requirement for dispensing narcotic 

drugs in schedule III, IV, or V (such as buprenorphine) for maintenance 

or detoxification treatment, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 25, 2021 

Mr. TONKO (for himself, Mr. TURNER, Mr. DELGADO, Mr. GONZALEZ of Ohio, 

Ms. BARRAGA ́N, Ms. BASS, Ms. BLUNT ROCHESTER, Ms. BROWNLEY, 

Mr. CARBAJAL, Mr. CA ́RDENAS, Mr. CASE, Ms. CLARKE of New York, 

Mr. RODNEY DAVIS of Illinois, Ms. DEAN, Mr. GALLEGO, Mr. HASTINGS, 

Mr. HIGGINS of New York, Mr. FITZPATRICK, Ms. JAYAPAL, Mr. JONES, 

Mr. KATKO, Mr. KIM of New Jersey, Ms. KUSTER, Mr. LAWSON of Florida, Mr. LEVIN of California, Ms. MATSUI, Mr. MEEKS, Mr. NADLER, 

Mrs. NAPOLITANO, Ms. NORTON, Mr. O’HALLERAN, Mr. PASCRELL, Mr. 

PAYNE, Ms. PINGREE, Mr. RASKIN, Miss RICE of New York, Ms. SCANLON, Mr. SCHRADER, Mr. SMITH of Washington, Ms. STRICKLAND, Mr. 

SUOZZI, Mr. TAYLOR, Mr. TRONE, Ms. UNDERWOOD, Mrs. WATSON

COLEMAN, Mr. WELCH, Ms. WILD, and Ms. ADAMS) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the 

Judiciary, for a period to be subsequently determined by the Speaker, in 

each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend section 303(g) of the Controlled Substances Act 

(21 U.S.C. 823(g)) to eliminate the separate registration 

requirement for dispensing narcotic drugs in schedule 

III, IV, or V (such as buprenorphine) for maintenance 

or detoxification treatment, and for other purposes. 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•HR 1384 IH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Mainstreaming Addic5 tion Treatment Act of 2021’’. 

6 SEC. 2. ELIMINATING SEPARATE REGISTRATION REQUIRE7 MENT FOR DISPENSING NARCOTIC DRUGS IN 

8 SCHEDULE III, IV, AND V FOR MAINTENANCE 

9 OR DETOXIFICATION TREATMENT. 

10 (a) IN GENERAL.—Section 303 of the Controlled 

11 Substances Act (21 U.S.C. 823) is amended— 

12 (1) by striking paragraph (2) of subsection (g); 

13 and 

14 (2) in subsection (g), as amended— 

15 (A) by striking ‘‘(g)(1) Except as provided 

16 in paragraph (2), practitioners who dispense 

17 narcotic drugs to individuals for maintenance 

18 treatment or detoxification treatment’’ and in19 serting ‘‘(g) Practitioners who dispense narcotic 

20 drugs (other than narcotic drugs in schedule 

21 III, IV, or V) to individuals for maintenance 

22 treatment or detoxification treatment’’; 

23 (B) by redesignating subparagraphs (A), 

24 (B), and (C) as paragraphs (1), (2), and (3), 

25 respectively; and 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•HR 1384 IH

1 (C) in paragraph (2), as redesignated, by 

2 redesignating clauses (i) and (ii) as subpara3 graphs (A) and (B), respectively. 

4 (b) CONFORMING CHANGES.— 

5 (1) Subsections (a) and (d)(1) of section 304 of 

6 the Controlled Substances Act (21 U.S.C. 824) are 

7 amended by striking ‘‘303(g)(1)’’ each place it ap8 pears and inserting ‘‘303(g)’’. 

9 (2) Section 309A(a)(2) of the Controlled Sub10 stances Act (21 U.S.C. 829a) is amended— 

11 (A) in the matter preceding subparagraph 

12 (A), by striking ‘‘the controlled substance is to 

13 be administered for the purpose of maintenance 

14 or detoxification treatment under section 

15 303(g)(2)’’ and inserting ‘‘the controlled sub16 stance is a narcotic drug in schedule III, IV, or 

17 V to be administered for the purpose of mainte18 nance or detoxification treatment’’; and 

19 (B) by striking ‘‘and—’’ and all that fol20 lows through ‘‘is to be administered by injection 

21 or implantation;’’ and inserting ‘‘and is to be 

22 administered by injection or implantation;’’. 

23 (3) Section 520E–4(c) of the Public Health 

24 Service Act (42 U.S.C. 290bb–36d(c)) is amended 

25 by striking ‘‘information on any qualified practiVerDate Sep 11 2014 15:43 Mar 24, 2021 Jkt 019200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H1384.IH H1384

pamtmann on DSKBC07HB2PROD with BILLS
4 

•HR 1384 IH

1 tioner that is certified to prescribe medication for 

2 opioid dependency under section 303(g)(2)(B) of the 

3 Controlled Substances Act’’ and inserting ‘‘informa4 tion on any practitioner who prescribes narcotic 

5 drugs in schedule III, IV, or V of section 202 of the 

6 Controlled Substances Act for the purpose of main7 tenance or detoxification treatment’’. 

8 (4) Section 544(a)(3) of the Public Health 

9 Service Act (42 U.S.C. 290dd–3) is amended by 

10 striking ‘‘any practitioner dispensing narcotic drugs 

11 pursuant to section 303(g) of the Controlled Sub12 stances Act’’ and inserting ‘‘any practitioner dis13 pensing narcotic drugs for the purpose of mainte14 nance or detoxification treatment’’. 

15 (5) Section 1833(bb)(3)(B) of the Social Secu16 rity Act (42 U.S.C. 1395l(bb)(3)(B)) is amended by 

17 striking ‘‘first receives a waiver under section 303(g) 

18 of the Controlled Substances Act on or after Janu19 ary 1, 2019’’ and inserting ‘‘first begins prescribing 

20 narcotic drugs in schedule III, IV, or V of section 

21 202 of the Controlled Substances Act for the pur22 pose of maintenance or detoxification treatment on 

23 or after January 1, 2021’’. 

24 (6) Section 1834(o)(3)(C)(ii) of the Social Se25 curity Act (42 U.S.C. 1395m(o)(3)(C)(ii)) is amendVerDate Sep 11 2014 15:43 Mar 24, 2021 Jkt 019200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H1384.IH H1384

pamtmann on DSKBC07HB2PROD with BILLS
5 

•HR 1384 IH

1 ed by striking ‘‘first receives a waiver under section 

2 303(g) of the Controlled Substances Act on or after 

3 January 1, 2019’’ and inserting ‘‘first begins pre4 scribing narcotic drugs in schedule III, IV, or V of 

5 section 202 of the Controlled Substances Act for the 

6 purpose of maintenance or detoxification treatment 

7 on or after January 1, 2021’’. 

8 (7) Section 1866F(c)(3) of the Social Security 

9 Act (42 U.S.C. 1395cc–6(c)(3)) is amended— 

10 (A) in subparagraph (A), by inserting 

11 ‘‘and’’ at the end; 

12 (B) in subparagraph (B), by striking ‘‘; 

13 and’’ and inserting a period; and 

14 (C) by striking subparagraph (C). 

15 (8) Section 1903(aa)(2)(C) of the Social Secu16 rity Act (42 U.S.C. 1396b(aa)(2)(C)) is amended— 

17 (A) in clause (i), by inserting ‘‘and’’ at the 

18 end; and 

19 (B) by striking clause (ii). 

20 SEC. 3. NATIONAL EDUCATION CAMPAIGN. 

21 (a) IN GENERAL.—The Secretary of Health and 

22 Human Services, acting through the Assistant Secretary 

23 for Mental Health and Substance Use, shall conduct a na24 tional campaign to educate practitioners with respect to 

25 the elimination of the separate registration requirement 


pamtmann on DSKBC07HB2PROD with BILLS
6 

•HR 1384 IH

1 under section 303(g) of the Controlled Substances Act (21 

2 U.S.C. 823(g)), as in effect on the day before the date 

3 of enactment of this Act, for dispensing narcotic drugs in 

4 schedule III, IV, and V for maintenance or detoxification 

5 treatment. 

6 (b) REQUIRED COMPONENTS.—The national edu7 cation campaign under subsection (a) shall— 

8 (1) encourage practitioners to integrate sub9 stance use treatment into their practices; and 

10 (2) include education on publicly available edu11 cational resources and training modules that can as12 sist practitioners in treating patients with a sub13 stance use disorder. 

14 SEC. 4. COMMUNITY HEALTH AIDES AND COMMUNITY 

15 HEALTH PRACTITIONERS. 

16 (a) PRACTICE OF TELEMEDICINE.—Section 102 of 

17 the Controlled Substances Act (21 U.S.C. 802) is amend18 ed— 

19 (1) in paragraph (54)(A), by striking clause (i) 

20 and inserting the following: 

21 ‘‘(i) while the patient is— 

22 ‘‘(I) being treated by, and physically 

23 located in, a hospital or clinic registered 

24 under section 303(f); or 


pamtmann on DSKBC07HB2PROD with BILLS
7 

•HR 1384 IH

1 ‘‘(II) for purposes of section 302(h), 

2 being treated by a community health aide 

3 or community health practitioner; and’’; 

4 (2) by redesignating paragraph (58) as para5 graph (59); 

6 (3) by redesignating the second paragraph des7 ignated as paragraph (57) as paragraph (58); 

8 (4) by moving paragraphs (57), (58) (as so re9 designated), and (59) (as so redesignated) 2 ems to 

10 the left; and 

11 (5) by adding at the end the following: 

12 ‘‘(60) The terms ‘community health aide’ and ‘com13 munity health practitioner’ have the meanings given to 

14 such terms for purposes of section 119 of the Indian 

15 Health Care Improvement Act (25 U.S.C. 1616l).’’. 

16 (b) DISPENSATION OF NARCOTIC DRUGS IN SCHED17 ULE III, IV, OR V.—Section 302 of the Controlled Sub18 stances Act (21 U.S.C. 822) is amended by adding at the 

19 end the following: 

20 ‘‘(h) DISPENSATION OF NARCOTIC DRUGS IN SCHED21 ULE III, IV, OR V BY CERTAIN PRACTITIONERS.— 

22 ‘‘(1) IN GENERAL.—Notwithstanding subsection 

23 (a)(2), a community health aide or community 

24 health practitioner may dispense a narcotic drug in 

25 schedule III, IV, or V, such as buprenorphine, or a 


pamtmann on DSKBC07HB2PROD with BILLS
8 

•HR 1384 IH

1 combination of such drugs, to an individual for 

2 maintenance treatment or detoxification treatment 

3 (or both) without being registered under this title if 

4 the drug is prescribed by a practitioner through the 

5 practice of telemedicine. 

6 ‘‘(2) PREEMPTION.—Notwithstanding section 

7 708, a State may not require a community health 

8 aide or community health practitioner to be licensed 

9 by the State in order to dispense narcotic drugs in 

10 accordance with paragraph (1) of this subsection.’’. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS